Speaker Spotlight: Dr. Babatope Lanre Awosusi at the 12th International Cancer Conference 2026
12th International Cancer, Oncology & Therapy Conference & Exhibition
April 09–11, 2026 | Dubai, UAE
The 12th International Cancer, Oncology & Therapy Conference & Exhibition is honored to welcome Dr. Babatope Lanre Awosusi as a distinguished speaker, bringing valuable expertise in histopathology and diagnostic oncology to this year’s scientific program.
About the Speaker
Dr. Babatope Lanre Awosusi, MBChB, MWACP, DipRCPath, FMCPath Head of the Histopathology Department King Khalid General Hospital, Al Majmaah, Saudi Arabia
Dr. Awosusi is an accomplished Anatomical Pathologist with over six years of clinical and diagnostic experience. He currently leads the Histopathology Department at King Khalid General Hospital, where he plays a pivotal role in advancing diagnostic accuracy and multidisciplinary cancer care.
He holds professional qualifications from:
West African College of Physicians (WACP)
Royal College of Pathologists (UK)
National Postgraduate Medical College of Nigeria
Dr. Awosusi is licensed to practice in the United Kingdom, Saudi Arabia, and Nigeria, reflecting his broad international clinical engagement.
His areas of expertise include:
Surgical Pathology
Cytopathology
Autopsy Pathology
With special research interests in:
Urological Pathology
Gynaecological Pathology
Hematopathology
Beyond diagnostics, he actively contributes to medical education, peer review, and research, supporting the global effort to enhance cancer detection and patient outcomes.
Presentation Highlight
Calciphylaxis in a Postmenopausal Woman on Dialysis for Chronic Kidney Disease
At the conference, Dr. Awosusi will present an insightful case-based discussion on calciphylaxis, a rare but life-threatening condition often seen in patients with advanced chronic kidney disease.
This session will explore:
The pathophysiological mechanisms linking metabolic disorders and vascular calcification
Histopathological challenges in diagnosing calciphylaxis
The importance of early recognition in oncology and chronic disease management
Multidisciplinary approaches to improving prognosis in high-risk patients
The intersection between renal disease, systemic pathology, and cancer-related complications
This presentation underscores how precise pathological evaluation can directly influence treatment pathways, patient safety, and survival outcomes.
Why This Session Matters
As oncology care becomes increasingly interdisciplinary, understanding complex comorbidities such as calciphylaxis is essential for:
Oncologists managing patients with chronic systemic diseases
Pathologists refining diagnostic accuracy
Nephrologists and clinicians coordinating integrated care
Researchers studying disease mechanisms at the cellular level
Dr. Awosusi’s work highlights the critical role of pathology in bridging diagnostics and therapeutic decision-making in modern cancer care.
Join Us in Dubai
The 12th International Cancer, Oncology & Therapy Conference & Exhibition brings together global leaders in oncology, diagnostics, and translational research to exchange knowledge, foster collaboration, and drive innovation in cancer treatment.
📅 Date: April 09–11, 2026
📍 Location: Dubai, UAE
🌐 Hybrid Participation Available (In-Person & Virtual)
This event offers a dynamic platform for clinicians, researchers, and healthcare professionals to engage with emerging science, real-world case studies, and transformative technologies shaping the future of oncology.
